BMO Capital analyst, Alex Arfei, reiterated his Outperform rating on shares of Pfizer (NYSE: PFE) after announcing Inflectra's U.S. launch ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE